Wedbush Raises price Target on NCR Corp. (NCR) Following 3Q; Reiterates Neutral
- Stocks face worst month since September, yen swings after BoJ
- Microsoft fiscal Q3 results top estimates as AI revolution spurs cloud growth
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
- Oil prices on track to snap two-week losing streak
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
After-Hours Movers 10/25: (OGXI) (AKAM) (VRTX) Higher; (EW) (NUVA) (CMG) (AAPL) Lower (more...)
October 25, 2016 6:03 PM EDTToday's After-Hours Movers
OncoGenex Pharmaceuticals, Inc. (Nasdq: OGXI) 35% HIGHER; announced positive survival results from the final analysis of the Phase 2 Borealis-2 trial of apatorsen in combination with docetaxel treatment that enrolled 200 patients with metastatic bladder cancer whose disease had progressed following first-line platinum-based chemotherapy. Patients who received apatorsen treatment experienced a 20% reduction in risk of death, compared to patients receiving docetaxel alone (HR=.80; 95% CI: 0.65-0.98; p=0.078). The primary analysis was a superiority test of overall survival, performed at a one-sided 0.10 significance level using a stratified log-rank test. The trial was conducted by the Hoosier... More
NCR Corp. (NCR) Tops Q3 EPS by 6c, Raises FY Guidance
October 25, 2016 4:21 PM EDTNCR Corp. (NYSE: NCR) reported Q3 EPS of $0.87, $0.06 better than the analyst estimate of $0.81. Revenue for the quarter came in at $1.68 billion versus the consensus estimate of $1.63 billion.
GUIDANCE:
NCR Corp. sees FY2016 EPS of $2.97-$3.02, versus prior guidance... More
Trading Radar for 10/25: Apple (AAPL), Caterpillar (CAT), Chipotle (CMG), Under Armour (UA), Juniper (JNPR) Report
October 24, 2016 2:16 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
9:00am EDT
Earnings:
3M Co. (NYSE: MMM) - consensus EPS $2.13
AK Steel (NYSE: AKS) - consensus EPS $0.13
AVANGRID, Inc. (NYSE: AGR) - consensus EPS $0.59
Allegheny Technologies (NYSE: ATI) - consensus loss $0.10
Allegiance... More